Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
363.12 USD | +0.14% |
|
-3.52% | +20.89% |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.73 | 12.32 | 10.97 | 11.08 | 11.39 | |||||
Return on Total Capital | 12.68 | 16.3 | 14.44 | 14.49 | 14.86 | |||||
Return On Equity % | 377.05 | 352.48 | 965.25 | 1.23T | 824.4 | |||||
Return on Common Equity | -335.78 | -3.85T | -305.03 | -230.87 | -269.6 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.32 | 38.28 | 38.48 | 39.37 | 40.62 | |||||
SG&A Margin | 1.79 | 1.68 | 1.62 | 1.53 | 1.49 | |||||
EBITDA Margin % | 19.26 | 21.33 | 19.96 | 19.55 | 19.63 | |||||
EBITA Margin % | 14.03 | 16.52 | 15.1 | 14.85 | 14.96 | |||||
EBIT Margin % | 13.98 | 16.47 | 15.03 | 14.82 | 14.94 | |||||
Income From Continuing Operations Margin % | 8.51 | 13.14 | 11.35 | 9.38 | 9.43 | |||||
Net Income Margin % | 7.28 | 11.84 | 9.37 | 8.07 | 8.16 | |||||
Net Avail. For Common Margin % | 7.28 | 11.84 | 9.37 | 8.07 | 8.16 | |||||
Normalized Net Income Margin | 5.65 | 7.45 | 5.66 | 6.11 | 6.26 | |||||
Levered Free Cash Flow Margin | 9.02 | 6.94 | 5.12 | 4.42 | 5.55 | |||||
Unlevered Free Cash Flow Margin | 10.88 | 8.56 | 6.88 | 6.23 | 7.32 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.11 | 1.2 | 1.17 | 1.2 | 1.22 | |||||
Fixed Assets Turnover | 2.07 | 2.29 | 2.24 | 2.26 | 2.3 | |||||
Receivables Turnover (Average Receivables) | 7.13 | 7.75 | 7.08 | 6.89 | 6.8 | |||||
Inventory Turnover (Average Inventory) | 16.68 | 18.08 | 18.28 | 19.27 | 22.31 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.42 | 1.41 | 1.38 | 1.18 | 1.08 | |||||
Quick Ratio | 1.03 | 1.01 | 1 | 0.87 | 0.84 | |||||
Operating Cash Flow to Current Liabilities | 1.06 | 0.93 | 0.86 | 0.75 | 0.69 | |||||
Days Sales Outstanding (Average Receivables) | 51.31 | 47.11 | 51.54 | 53 | 53.81 | |||||
Days Outstanding Inventory (Average Inventory) | 21.95 | 20.19 | 19.97 | 18.95 | 16.41 | |||||
Average Days Payable Outstanding | 36.29 | 38.52 | 41.03 | 39.3 | 37.39 | |||||
Cash Conversion Cycle (Average Days) | 36.97 | 28.77 | 30.47 | 32.65 | 32.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.14T | 2.47T | -55.07T | 3.95T | 8.15T | |||||
Total Debt / Total Capital | 91.97 | 96.1 | 100.18 | 97.53 | 98.79 | |||||
LT Debt/Equity | 1.12T | 2.42T | -54.06T | 3.69T | 7.24T | |||||
Long-Term Debt / Total Capital | 90.33 | 94.44 | 98.35 | 91.04 | 87.78 | |||||
Total Liabilities / Total Assets | 93.91 | 97.07 | 100.14 | 98.11 | 99.07 | |||||
EBIT / Interest Expense | 4.55 | 6.18 | 5.2 | 4.97 | 5.12 | |||||
EBITDA / Interest Expense | 6.85 | 8.63 | 7.47 | 7.07 | 7.23 | |||||
(EBITDA - Capex) / Interest Expense | 5.06 | 6.35 | 4.94 | 4.62 | 4.87 | |||||
Total Debt / EBITDA | 3.05 | 2.72 | 3.09 | 3.06 | 3.03 | |||||
Net Debt / EBITDA | 2.88 | 2.6 | 3.02 | 2.98 | 2.9 | |||||
Total Debt / (EBITDA - Capex) | 4.13 | 3.69 | 4.67 | 4.67 | 4.51 | |||||
Net Debt / (EBITDA - Capex) | 3.89 | 3.54 | 4.56 | 4.56 | 4.31 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 0.38 | 14.01 | 2.52 | 7.86 | 8.67 | |||||
Gross Profit, 1 Yr. Growth % | -0.34 | 16.6 | 3.05 | 10.36 | 12.12 | |||||
EBITDA, 1 Yr. Growth % | 1.11 | 25.52 | -4.06 | 5.67 | 9.1 | |||||
EBITA, 1 Yr. Growth % | -0.03 | 33.14 | -6.25 | 6.05 | 9.51 | |||||
EBIT, 1 Yr. Growth % | -0.22 | 33.27 | -6.46 | 6.34 | 9.57 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 5.84 | 76 | -11.49 | -10.87 | 9.29 | |||||
Net Income, 1 Yr. Growth % | 7.1 | 85.3 | -18.88 | -7.11 | 9.88 | |||||
Normalized Net Income, 1 Yr. Growth % | 5.58 | 48.35 | -22.13 | 16.53 | 11.37 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 8.54 | 93.6 | -9.5 | -0.94 | 15.97 | |||||
Accounts Receivable, 1 Yr. Growth % | -4.47 | 14.83 | 9.83 | 11.94 | 8.33 | |||||
Inventory, 1 Yr. Growth % | 9.52 | -1.93 | 4.13 | -2.27 | -14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.75 | 3.78 | 5.59 | 8.26 | 5.42 | |||||
Total Assets, 1 Yr. Growth % | 5.4 | 6.85 | 3.34 | 7.2 | 5.87 | |||||
Tangible Book Value, 1 Yr. Growth % | -27.72 | 30.81 | 18.59 | -5.64 | 7.45 | |||||
Common Equity, 1 Yr. Growth % | -120.37 | -263.11 | 196.57 | -35.89 | 40.87 | |||||
Cash From Operations, 1 Yr. Growth % | 21.44 | -2.96 | -4.88 | 10.67 | 11.48 | |||||
Capital Expenditures, 1 Yr. Growth % | -31.82 | 26.17 | 22.87 | 7.94 | 2.76 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 144.17 | -12.95 | -24.42 | -6.76 | 36.29 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 86.09 | -10.9 | -17.67 | -2.2 | 27.65 | |||||
Dividend Per Share, 1 Yr. Growth % | -73.12 | 346.51 | 16.67 | 7.14 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.07 | 6.98 | 8.11 | 5.16 | 8.27 | |||||
Gross Profit, 2 Yr. CAGR % | 4.74 | 7.97 | 9.61 | 6.64 | 11.24 | |||||
EBITDA, 2 Yr. CAGR % | 5.47 | 13 | 9.74 | 0.69 | 7.36 | |||||
EBITA, 2 Yr. CAGR % | 4.32 | 15.94 | 11.92 | -0.16 | 8.01 | |||||
EBIT, 2 Yr. CAGR % | 4.13 | 15.79 | 11.65 | -0.26 | 7.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -0.02 | 36.48 | 24.81 | -11.18 | -1.3 | |||||
Net Income, 2 Yr. CAGR % | -0.44 | 40.88 | 22.6 | -13.19 | 1.03 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.57 | 25.95 | 7.48 | -4.74 | 13.9 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.26 | 44.96 | 32.37 | -5.32 | 7.18 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.89 | 4.74 | 12.3 | 10.88 | 10.12 | |||||
Inventory, 2 Yr. CAGR % | 8.13 | 3.64 | 1.06 | 0.88 | -8.33 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 12.99 | 3.26 | 4.68 | 6.92 | 6.83 | |||||
Total Assets, 2 Yr. CAGR % | 10.06 | 6.12 | 5.08 | 5.25 | 6.53 | |||||
Tangible Book Value, 2 Yr. CAGR % | -21.23 | -2.76 | 24.55 | 5.78 | 0.69 | |||||
Common Equity, 2 Yr. CAGR % | -66.01 | -42.36 | 119.94 | 37.89 | -4.97 | |||||
Cash From Operations, 2 Yr. CAGR % | 16.85 | 8.56 | -3.92 | 2.6 | 11.07 | |||||
Capital Expenditures, 2 Yr. CAGR % | -10.92 | -7.25 | 24.51 | 15.16 | 5.32 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 38.91 | 46.38 | -18.89 | -16.06 | 12.71 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 27.04 | 29.2 | -14.35 | -10.27 | 11.71 | |||||
Dividend Per Share, 2 Yr. CAGR % | -44.58 | 9.54 | 128.24 | 11.8 | 8.56 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.72 | 7.97 | 5.47 | 8.03 | 6.32 | |||||
Gross Profit, 3 Yr. CAGR % | 5.8 | 8.67 | 6.3 | 9.86 | 8.44 | |||||
EBITDA, 3 Yr. CAGR % | 6.62 | 12 | 7 | 8.37 | 3.41 | |||||
EBITA, 3 Yr. CAGR % | 6.08 | 13.47 | 8.02 | 9.93 | 2.96 | |||||
EBIT, 3 Yr. CAGR % | 5.95 | 13.37 | 7.84 | 9.85 | 2.91 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.94 | 20.72 | 18.14 | 11.56 | -4.82 | |||||
Net Income, 3 Yr. CAGR % | 19.21 | 22.47 | 17.2 | 11.77 | -6.1 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.31 | 20.99 | 7.3 | 10.41 | 0.35 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 22.47 | 25.68 | 23.89 | 20.18 | 1.31 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.76 | 6.04 | 6.41 | 12.18 | 10.02 | |||||
Inventory, 3 Yr. CAGR % | 8.78 | 4.67 | 3.8 | -0.07 | -4.35 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.12 | 9.83 | 4.03 | 5.86 | 6.42 | |||||
Total Assets, 3 Yr. CAGR % | 9.08 | 8.98 | 5.19 | 5.78 | 5.46 | |||||
Tangible Book Value, 3 Yr. CAGR % | -17.39 | -6.72 | 3.89 | 13.54 | 6.33 | |||||
Common Equity, 3 Yr. CAGR % | -56.2 | -42.66 | -0.49 | 45.83 | 38.88 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.38 | 9.84 | 3.88 | 0.71 | 5.48 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.03 | 0.04 | 1.86 | 18.72 | 10.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 40.23 | 19.19 | 17.43 | -15.03 | -1.34 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 27.42 | 13.13 | 11.18 | -10.48 | 0.91 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 11.1 | 11.87 | 77.38 | 11.2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.37 | 7.21 | 6.67 | 6.84 | 6.58 | |||||
Gross Profit, 5 Yr. CAGR % | 5.2 | 7.51 | 7.37 | 7.85 | 8.25 | |||||
EBITDA, 5 Yr. CAGR % | 4.75 | 8.95 | 7.99 | 7.33 | 7.15 | |||||
EBITA, 5 Yr. CAGR % | 3.92 | 9.38 | 8.48 | 7.75 | 7.91 | |||||
EBIT, 5 Yr. CAGR % | 3.84 | 9.32 | 8.38 | 7.71 | 7.88 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.23 | 17.6 | 20.03 | 6.77 | 9.94 | |||||
Net Income, 5 Yr. CAGR % | 12.01 | 19.2 | 20.56 | 6.72 | 10.45 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.26 | 13.74 | 8.85 | 9.95 | 9.9 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.98 | 23.72 | 26.34 | 12.22 | 16.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.66 | 6.8 | 6.47 | 7.95 | 7.88 | |||||
Inventory, 5 Yr. CAGR % | 7.07 | 5.73 | 5.62 | 3.13 | -1.23 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.93 | 9.87 | 9.08 | 8.66 | 5.14 | |||||
Total Assets, 5 Yr. CAGR % | 7.72 | 8.49 | 7.46 | 7.47 | 5.72 | |||||
Tangible Book Value, 5 Yr. CAGR % | -10.99 | -5.65 | -2.64 | -1.91 | 2.6 | |||||
Common Equity, 5 Yr. CAGR % | -40.39 | -33.73 | -16.47 | -18.55 | -2.3 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.29 | 9.65 | 9.45 | 6.88 | 6.7 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.6 | 5.32 | 7.83 | 5.83 | 3.23 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.29 | 8.74 | 12.83 | 3.6 | 15.52 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.91 | 6.24 | 8.85 | 3.11 | 11.4 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 11.38 | 10.53 |
- Stock Market
- Equities
- HCA Stock
- Financials HCA Healthcare, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition